Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

The Use of Oral Antibiotics Before Isotretinoin Therapy in Patients with Acne

Description

The presentation discusses a study on the use of oral antibiotics prior to isotretinoin therapy in patients with acne, a common condition affecting millions in the US. The study, conducted from 2005 to 2014, involved a retrospective chart review of 137 patients who received isotretinoin. Key findings revealed that the average duration of antibiotic treatment before isotretinoin was 331 days, with many patients exceeding the guideline-recommended duration. Notably, the study highlighted increased risks of prolonged antibiotic use among patients receiving care from multiple providers and indicated that women faced delays in transitioning to isotretinoin due to regulatory barriers. The authors emphasize the responsibility of dermatologists to identify patients requiring isotretinoin sooner to reduce excessive antibiotic exposure. This transition is critical in addressing concerns such as antibiotic resistance and potential adverse health effects associated with prolonged antibiotic use. The study advocates for early recognition of antibiotic failure and a quicker approach to isotretinoin therapy to benefit both the patients and the broader healthcare system.

View more

Conclusions

  • Patients requiring isotretinoin experience prolonged exposure to antibiotics that exceeds recommended durations.
  • Multiple provider consultations significantly increase the risk of extended antibiotic use.
  • Women of childbearing potential face additional barriers that can delay isotretinoin prescriptions and prolong antibiotic use.
  • Early identification of treatment failure and quicker transitions to isotretinoin can help reduce unnecessary antibiotic exposure.
  • Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, Freeman EE, Keri JE, Stein Gold LF, Tan JKL, Tollefson MM, Weiss JS, Wu PA, Zaenglein AL, Han JM, Barbieri JS. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024 Jan 30:S0190-9622(23)03389-3. doi: 10.1016/j.jaad.2023.12.017. Epub ahead of print.
  • Delost GR, Delost ME, Armile J, Lloyd J. Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris. J Am Acad Dermatol. 2016;74(4):673-678.
  • Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. 2005;141(9):1132-1136.
  • Margolis DJ, Fanelli M, Hoffstad O, Lewis JD. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol. 2010;105(12):2610-2616.
  • Cao Y, Wu K, Mehta R, et al. Long-term use of antibiotics and risk of colorectal adenoma. Gut. April 2017.
  • Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291(7):827-835.